Drugs / Brinzolamide 1%/Brimonidine 0.2%
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT01978600 | Oct 2013 → Mar 2014 | ocular hypertension, open-angle glaucoma | Alcon Research | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Brinzolamide 1%/Brimonidine 0.2% | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01978600 ↗ |
| Route | Topical | “Brinzolamide 1%/Brimonidine 0.2% ophthalmic suspension, 1 drop 3 times a day (8AM, 3PM, 10PM) in each eye for 4 weeks” NCT01978600 ↗ |